Where does KetoLipix Therapeutics GmbH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), KetoLipix Therapeutics GmbH ranks #41,216 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does KetoLipix Therapeutics GmbH hold?

KetoLipix Therapeutics GmbH holds 6 US utility patents granted between 2024 and 2025, spanning 7 technology areas.

What is KetoLipix Therapeutics GmbH's Innovation Score?

KetoLipix Therapeutics GmbH has an Innovation Score of 36.5 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does KetoLipix Therapeutics GmbH focus on?

KetoLipix Therapeutics GmbH's top technology area is C07C (Acyclic OR Carbocyclic Compounds) with 6 patents, ranking #724 of 2,691 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is KetoLipix Therapeutics GmbH's patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for KetoLipix Therapeutics GmbH.

What does claim depth mean for KetoLipix Therapeutics GmbH's patents?

KetoLipix Therapeutics GmbH's patents average 11.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the KetoLipix Therapeutics GmbH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

KetoLipix Therapeutics GmbH

USPTO PatentsView assignee record - 6 granted patents across 7 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07C (Acyclic OR Carbocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ketolipix ranks #41,216 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 7 technology areas.

#41,216
of 49,997 US assignees by volume: Top 46%
by Innovation Score (36.5/100): 11.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R41216 · Foreign Corporation #41,216 · 6 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 6 grants
LOWER-Q #41,216/49,997
PHOTO-FINISH Kent Precision…
CPC-NARROW C07C · 7 areas
INNOV-THIN 36.5/100
CLAIMS-PAR 11.8 claims/avg
TYPE-FRNCORP Foreign Corp
SPAN-YRS 2024–2025 · 2y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Kent Precision Foods Group, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ketolipix’s 36.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.7 pts (18%) Velocity 13.3 pts (36%) Breadth 9.4 pts (26%) Claim depth 7.1 pts (19%)

Qualcomm Incorporated · highest

85
Epica International · near

37
KetoLipix Therapeutics · this assignee

37
Leeo · near

37
Nguyen Gaming · near

37
Shenzhen Envision… · near

37
3D Lighting… · lowest

7

What this shows Ketolipix's Innovation Score is 36.5/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ketolipix?

Each dot is one of Ketolipix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ketolipix’s own 11.8 claims/patent is at or below the 20.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Ketolipix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ketolipix's grants concentrate

KetoLipix Therapeutics GmbH is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C07C (Acyclic OR Carbocyclic Compounds). By volume, Ketolipix sits between Kent Precision Foods Group, Inc. and Kiln Drying Systems & Components, LLC.

Ketolipix's three-year grant acceleration

KetoLipix Therapeutics GmbH shows 2 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Kent Precision Fo…

6
Kentucky Imaging

6
Kenyon

6
Kerflummox Holdin…

6
Keypoint India Pvt

6
Keystone Engineer…

6
Keystone Integrat…

6
Kiln Drying Syste…

6
Ketolipix Therape… ◀

6

What this shows KetoLipix holds 6 patents at rank #41,249, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near KetoLipix

By rank, the assignees closest to #41,249 in granted patent volume.

Leaders in C07C (Acyclic OR Carbocyclic Compounds)

Other assignees with the most granted patents in KetoLipix's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for KetoLipix, neither rank-band nor same-CPC leaders (those blocks stay above). In C07C (Acyclic OR Carbocyclic Compounds), KetoLipix ranks #724 of 2,691 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Leeo, Inc. 37 Shenzhen Envision Technology Innovation Co., Ltd. 37 Epica International, Inc. 37 Nguyen Gaming LLC 37

Ketolipix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 46% higher than 54% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2024–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.

View data table

KetoLipix Therapeutics GmbH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2024	2	33.3%
2025partial year	4	66.7%

Which technologies does KetoLipix Therapeutics GmbH patent most?

C07C - Acyclic OR Carbocyclic Compounds 6

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 5

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 5

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 5

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

A23D - Edible Oils OR Fats, e.g. Margarines, Shortenings OR Cooking Oils 1

C12Y - Enzymes 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

KetoLipix Therapeutics GmbH's patent record in context - here's where to go next.

KetoLipix Therapeutics GmbH's lead technology class is C07C (Acyclic OR Carbocyclic Compounds), 100% of its portfolio - see every assignee active in that class. Explore C07C
Ranked #41,216 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare KetoLipix Therapeutics GmbH against Kent Precision Foods Group, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.